Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Neuroforaminal Bone Growth Following Minimally Invasive Transforaminal Lumbar Interbody Fusion With BMP: A Computed Tomographic Analysis.
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
Glenoid subchondral bone density distribution in male total shoulder arthroplasty subjects with eccentric and concentric wear.
Toxicology
Using conditioned place preference to identify relapse prevention medications.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Using conditioned place preference to identify relapse prevention medications.
Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev. 2013 Nov; 37(9 Pt A):2081-6.
View in:
PubMed
subject areas
Animals
Antidepressive Agents, Tricyclic
Behavior, Animal
Central Nervous System Stimulants
Humans
Motivation
Secondary Prevention